Active — Not RecruitingNot Applicable

Health Benefits of Air Purifiers in Primary School Students

China110 participantsStarted 2021-09-22

Plain-language summary

This study aims to explore changes in cardiopulmonary function and other health indicators in primary school students with the intervention of air purifiers on a randomized controlled trial.

Who can participate

Age range8 Years – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age of between 8 and 12 years old * Males and female of ethnic Han * Subjects who have no plans to change classroom during the intervention period * Subjects who staying in Jiaozuo city during the intervention period Exclusion Criteria: * Subjects with asthma, childhood diabetes, childhood hypertension, and behavioral disorders * Subjects who plan to transfer or move offsite within six months * Subjects who decorated or plan to decorate home within six months * Subjects with smokers in the household

What they're measuring

Changes of heart rate variability

Timeframe: Baseline and after the completion of intervention period (4 months anticipated)

Changes of forced expiratory volume in 1 s (FEV1)

Timeframe: Baseline and after the completion of intervention period (4 months anticipated)

Changes of forced vital capacity (FVC)

Timeframe: Baseline and after the completion of intervention period (4 months anticipated)

Changes of forced expiratory volume in 1 s (FEV1) / forced vital capacity (FVC) ratio

Timeframe: Baseline and after the completion of intervention period (4 months anticipated)

Changes of peak expiratory flow (PEF)

Timeframe: Baseline and after the completion of intervention period (4 months anticipated)

Changes of fractional exhaled nitric oxide (FeNO) levels

Timeframe: Baseline and after the completion of intervention period (4 months anticipated)

Changes of fractional exhaled carbon monoxide (FeCO) levels

Timeframe: Baseline and after the completion of intervention period (4 months anticipated)

Trial details

NCT IDNCT05016271

SponsorFudan University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06-30

View on ClinicalTrials.gov More Cardiopulmonary Function trials

Who can participate

Age range8 Years – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Changes of heart rate variability

Timeframe: Baseline and after the completion of intervention period (4 months anticipated)

Changes of forced expiratory volume in 1 s (FEV1)

Timeframe: Baseline and after the completion of intervention period (4 months anticipated)

Changes of forced vital capacity (FVC)

Timeframe: Baseline and after the completion of intervention period (4 months anticipated)

Changes of forced expiratory volume in 1 s (FEV1) / forced vital capacity (FVC) ratio

Timeframe: Baseline and after the completion of intervention period (4 months anticipated)

Changes of peak expiratory flow (PEF)

Timeframe: Baseline and after the completion of intervention period (4 months anticipated)

Changes of fractional exhaled nitric oxide (FeNO) levels

Timeframe: Baseline and after the completion of intervention period (4 months anticipated)

Changes of fractional exhaled carbon monoxide (FeCO) levels

Timeframe: Baseline and after the completion of intervention period (4 months anticipated)